BDX Trading Analysis - 11/06/2026 02:37 PM — TRU-SENTIMENT

BDX (Becton Dickinson and Co.) at $212.23. True Sentiment Bullish, delta 40-60 call 89% / put 11%, call $736,550 vs put $88,690. RSI 80.0.

TRU-SENTIMENT · DeltaNeutral

BDX Trading Analysis - 11/06/2026 02:37 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

BDX (Becton Dickinson and Co.) at $212.23. True Sentiment Bullish, delta 40-60 call 89% / put 11%, call $736,550 vs put $88,690. RSI 80.0.

Symbol
BDX
Price
$212.23
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-06 14:37:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bullish. Call dollar volume $736,550.00 (89.3%) vs put $88,690.00 (10.7%). Call contracts 543, put 207; call trades 10, put trades 2. Total analyzed 534, true sentiment 12 (2.2% filter).

Conviction: Strong directional call buying. Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" with advice to wait for alignment, yet technicals show clear bullish alignment and overbought RSI — divergence is in system interpretation, not raw data.

Note: Options flow shows heavy call buying at Delta 40-60 range, 89.3% call dollar share.

Key Statistics: BDX

$212.05 -0.31%
52-Week Range
$140.11 - $214.78
Market Cap
$57.76B
P/E (TTM)
63.00
PEG Ratio
N/A
Beta
-0.17
Next Earnings
N/A
Avg Volume
$1.15M
Dividend Yield
0.02%

Fundamental Snapshot

Valuation

P/E (trailing)63.00
EPS (trailing 12 mo)$3.32
Market cap$57.76B
Shares outstanding272.4M

Dividend

Dividend yield2.01%
Annual dividend$4.20
Ex-dividend date2026-09-09

Risk & range

Beta-0.17
52-week low$140.11
52-week high$214.78
Historical volatility25.6%

Ownership & trading

Institutional ownership70.7%
Average daily volume1.8M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Becton Dickinson (BDX) recently reported fiscal full-year results with steady medical device demand, though supply-chain normalization remained a theme across the healthcare sector.

BDX confirmed a quarterly dividend of $1.05 per share (ex-dividend date 2026-09-09), reinforcing its defensive income profile amid macro uncertainty.

Industry headlines have highlighted hospital capital expenditure recovery, a potential tailwind for BDX's instrumentation and diagnostics segments.

No major negative regulatory actions or product recalls were broadly reported in the recent period; however, elevated valuation in med-tech has drawn caution from some commentators.

Context: The bullish options flow and sharp November price surge contrast with a traditionally low-beta defensive profile, suggesting a sentiment-driven move rather than a fundamental catalyst shift.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E: 63.00; Trailing EPS: $3.32
  • Market Cap: $57,759,663,350.00; Shares Outstanding: 272,387,000
  • Dividend Yield: 2.01%; Annual Dividend Rate: $4.20; Ex-Dividend: 2026-09-09
  • Beta: -0.17 (inverse market correlation)
  • 52-Week High: $214.78; 52-Week Low: $140.11
  • Institutional Ownership: 70.71%
  • Average Volume: 1,845,000; Historical Volatility: 25.65%
  • Fiscal Year End: 2026-09-01

Revenue growth, profit margins, ROE, debt/equity, and free cash flow are not available in the data (null). Forward PE, PEG, and price/book are also null. The trailing P/E of 63.00 is elevated versus typical industrial/med-tech peers, suggesting a premium valuation. Analyst consensus and target price are null. Fundamentals show a stable dividend and defensive beta, but the high P/E diverges from the sharp technical rally and bullish options sentiment, indicating the move is not clearly supported by disclosed fundamental metrics.

Current Market Position

Current price per indicators: $212.72 (2026-11-05 close). Minute bars show 2026-11-05 open $208.00, high $213.16, low $206.50, close $211.86 early; daily 2026-11-05 close $212.72 with high $214.78. On 2026-11-06 at 14:05, last bar close $212.23, range $212.23–$212.57, low volume (5,745) indicating muted intraday momentum late session.

Price is at the top of the 30-day range (high $214.78, low $175.71) and above all major SMAs.

Resistance
$214.78
Support
$208.82
Lower Support
$195.43

Technical Analysis

Technical Indicators

RSI (14)
80.04
MACD
5.39 / 4.31 / 1.08
SMA 5
$203.06
SMA 20
$195.43
SMA 50
$187.58
Bollinger Mid
$195.43
Bollinger Up
$208.82
Bollinger Low
$182.05
ATR 14
4.30

SMAs are aligned bullish: 5 > 20 > 50 ($203.06 > $195.43 > $187.58), no bearish crossover. RSI 80.04 indicates overbought momentum. MACD histogram positive (1.08) confirms bullish momentum. Price is above upper Bollinger ($208.82), showing expansion. 30-day range: price near high $214.78, low $175.71.

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bullish. Call dollar volume $736,550.00 (89.3%) vs put $88,690.00 (10.7%). Call contracts 543, put 207; call trades 10, put trades 2. Total analyzed 534, true sentiment 12 (2.2% filter).

Conviction: Strong directional call buying. Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" with advice to wait for alignment, yet technicals show clear bullish alignment and overbought RSI — divergence is in system interpretation, not raw data.

Note: Options flow shows heavy call buying at Delta 40-60 range, 89.3% call dollar share.

Key Price Levels (Observational Only)

30d High / Resist
$214.78
Boll Upper
$208.82
SMA 20 / Boll Mid
$195.43
SMA 50
$187.58

Interactive charts load with JavaScript. This text is the crawlable summary.